Tartaric acid - paediatric investigation plan

tartaric acid

Key facts

• Active substance:
  tartaric acid
• Therapeutic area:
  Uro-nephrology
• Decision number:
  P/41/2010
• PIP number:
  Tartaric acid
• Pharmaceutical form(s):
  Nebuliser solution
• Condition(s) / indication(s):
  Stress incontinence, female
• Route(s) of administration:
  Inhalation use
• Decision type:
  W: decision granting a waiver in all age groups for all conditions or indications
• Decision date:
  31/03/2010
• Compliance check done:
  Ne

Decision

P/41/2010: European Medicines Agency decision of 31 March 2010 on the granting of a product specific waiver for tartaric acid (EMEA-000772-PIP01-09) in accordance with Regulation (EC) No 1901/2006 of the European Parliam...

Reference Number: EMA/173479/2010